443 related articles for article (PubMed ID: 15199446)
1. Low-molecular-weight heparins for the treatment of acute coronary syndromes.
Wong GC; Giugliano RP
Semin Vasc Med; 2003 Nov; 3(4):391-402. PubMed ID: 15199446
[TBL] [Abstract][Full Text] [Related]
2. Role of low-molecular-weight heparin in invasive management of non-ST-elevation acute coronary syndromes.
Moser LR; Kalus JS
Ann Pharmacother; 2004 Dec; 38(12):2094-104. PubMed ID: 15536140
[TBL] [Abstract][Full Text] [Related]
3. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
[TBL] [Abstract][Full Text] [Related]
4. The role of low-molecular-weight heparins in non-ST-segment elevation acute coronary syndromes.
Nguyen-Ho P; Levine GN
Panminerva Med; 2002 Jun; 44(2):115-22. PubMed ID: 12032429
[TBL] [Abstract][Full Text] [Related]
5. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
[TBL] [Abstract][Full Text] [Related]
6. Combination of low molecular weight heparins with antiplatelet agents in non-ST elevation acute coronary syndromes: an update.
Cohen M
Drugs; 2002; 62(12):1755-70. PubMed ID: 12149045
[TBL] [Abstract][Full Text] [Related]
7. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Fernandez JS; Sadaniantz A
Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658
[No Abstract] [Full Text] [Related]
8. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
Ferguson JJ; Wilson JM; Diez J
Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
[TBL] [Abstract][Full Text] [Related]
9. Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention.
Wong GC; Giugliano RP; Antman EM
JAMA; 2003 Jan; 289(3):331-42. PubMed ID: 12525234
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic therapy in unstable angina/non-ST elevation myocardial infarction: the evolving role of low-molecular-weight heparin.
Antman EM; Kereiakes DJ
J Invasive Cardiol; 2000 Dec; 12 Suppl E():E1-4;discussion E25-8. PubMed ID: 11156721
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparins and glycoprotein IIb/IIIa antagonists in acute coronary syndromes.
Ferguson J
J Invasive Cardiol; 2004 Mar; 16(3):136-44. PubMed ID: 15152164
[TBL] [Abstract][Full Text] [Related]
12. Acute and prolonged treatment with low-molecular-weight heparin therapy in patients with unstable coronary artery disease.
Husted S; Kher A
Ann Med; 2000 Dec; 32 Suppl 1():53-9. PubMed ID: 11209983
[TBL] [Abstract][Full Text] [Related]
13. Unstable angina and non-ST-segment myocardial infarction: an evidence-based approach to management.
Kou V; Nassisi D
Mt Sinai J Med; 2006 Jan; 73(1):449-68. PubMed ID: 16470325
[TBL] [Abstract][Full Text] [Related]
14. The role of low-molecular-weight heparins in the management of unstable angina and non-ST elevation myocardial infarction.
Alwi I
Acta Med Indones; 2008 Oct; 40(4):228-32. PubMed ID: 19530369
[TBL] [Abstract][Full Text] [Related]
15. Differences among low-molecular-weight heparins: evidence in patients with acute coronary syndromes.
Nicolau JC; Cohen M; Montalescot G
J Cardiovasc Pharmacol; 2009 Jun; 53(6):440-5. PubMed ID: 19365279
[TBL] [Abstract][Full Text] [Related]
16. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
Haas S
Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
[TBL] [Abstract][Full Text] [Related]
17. [How to administer antithrombotic therapy in non-ST-elevation acute coronary syndromes: guidelines and clinical practice].
Mafrici A
Ital Heart J; 2005 May; 6 Suppl 3():24S-27S. PubMed ID: 15945316
[TBL] [Abstract][Full Text] [Related]
18. Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B.
Turpie AG
Can J Cardiol; 1998 Aug; 14 Suppl E():20E-23E. PubMed ID: 9779029
[TBL] [Abstract][Full Text] [Related]
19. The use of antithrombotics for acute coronary syndromes in the emergency department: considerations and impact.
Mukherjee D; Eagle KA
Prog Cardiovasc Dis; 2007; 50(3):167-80. PubMed ID: 17976502
[TBL] [Abstract][Full Text] [Related]
20. Effect of un-fractionated heparin and low molecular weight heparin on hospital mortality in patients with non ST elevation acute coronary syndrome (ACS).
Angkasuwapala K; Ratanasumawong K; Ngarmukos T; Kehasukcharoen W; Boonsom W; Kamsa-ard S
J Med Assoc Thai; 2007 Oct; 90 Suppl 1():109-14. PubMed ID: 18431893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]